| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/27/2011 | US20110021513 Modulators of interleukin-1 receptor-associated kinase |
| 01/27/2011 | US20110021504 Polymorphic form d of bazedoxifene acetate and methods of preparing same |
| 01/27/2011 | US20110021502 Use of cholinesterase inhibitors for treating vascular depression |
| 01/27/2011 | US20110021497 Amino triazoles as pi3k inhibitors |
| 01/27/2011 | US20110021493 Substituted tricyclic compounds and methods of use thereof |
| 01/27/2011 | US20110021492 Pyridazine derivatives as factor xia inhibitors |
| 01/27/2011 | US20110021491 Compounds, pharmaceutical composition and methods relating thereto |
| 01/27/2011 | US20110021487 Cycloalkoxy-substituted 4-phenyl-3,5-dicyanopyridines and their use |
| 01/27/2011 | US20110021485 Indole derivatives and their metal conjugates and uses thereof |
| 01/27/2011 | US20110021468 Treatment of cardiovascular disease with salicylates |
| 01/27/2011 | US20110021466 Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling |
| 01/27/2011 | US20110021465 Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome |
| 01/27/2011 | US20110021462 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 01/27/2011 | US20110021457 Pharmaceutical compositions comprising modified fucans and methods relating thereto |
| 01/27/2011 | US20110021453 Methods and compositions for providing cardiac protection |
| 01/27/2011 | US20110021448 Inhibitors for the Soluble Epoxide Hydrolase |
| 01/27/2011 | US20110021446 Compositions and methods for feeding poultry |
| 01/27/2011 | US20110021434 Macrocyclic Cysteine Protease Inhibitors and Compositions Thereof |
| 01/27/2011 | US20110021433 Methods for treating or preventing heart failure |
| 01/27/2011 | US20110021432 Manufacture of factor h (fh) and fh-derivatives from plasma |
| 01/27/2011 | US20110021424 Polypeptide derived from protein a and able to bind pdgf |
| 01/27/2011 | US20110021419 Methods and Compositions for the Treatment of Heart Failure and Other Disorders |
| 01/27/2011 | US20110021418 Enriched haptoglobin polymers for the treatment of disease |
| 01/27/2011 | US20110021413 Methods of suppressing microglial activation |
| 01/27/2011 | US20110021377 Use of a trpc channel for the treatment of a cardiovascular disease |
| 01/27/2011 | US20110020471 Erythrocyte atp-release modulators |
| 01/27/2011 | US20110020460 Gpr 119 modulators |
| 01/27/2011 | US20110020455 Solid dispersion and pharmaceutical composition of the same, and production processes thereof |
| 01/27/2011 | US20110020433 Compositions for delivery of cargo such as drugs proteins and/or genetic materials |
| 01/27/2011 | US20110020407 Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracy |
| 01/27/2011 | US20110020400 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020389 Agents for promoting secretion and/or suppressing decrease of adiponectin |
| 01/27/2011 | US20110020375 Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use |
| 01/27/2011 | US20110020351 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 01/27/2011 | US20110020346 Anti-vegf antibodies |
| 01/27/2011 | US20110020338 5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes |
| 01/27/2011 | US20110020337 Methods for treating conditions associated with masp-2 dependent complement activation |
| 01/27/2011 | US20110020314 Identifying haematopoietic stem cells based on cell surface markers |
| 01/27/2011 | US20110020300 Compositions and methods for inhibiting expression of glucocorticoid receptor (gcr) genes |
| 01/27/2011 | US20110020284 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020270 Treatment and prophylaxis |
| 01/27/2011 | US20110020267 Tweak receptor |
| 01/27/2011 | US20110020227 Polysaccharide-containing block copolmer particles and uses thereof |
| 01/27/2011 | CA2770517A1 Cyclosporin conjugates |
| 01/27/2011 | CA2768980A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders |
| 01/26/2011 | EP2277887A2 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 01/26/2011 | EP2277879A1 Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 01/26/2011 | EP2277877A1 Quinazoline derivatives as kinase inhibitors |
| 01/26/2011 | EP2277876A1 Substituted pyrimidines for the treatment of cancer |
| 01/26/2011 | EP2277874A1 Activator for peroxisome proliferator-activated receptor |
| 01/26/2011 | EP2277861A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 01/26/2011 | EP2277857A2 New crystalline form V of agomelatine, method of preparing same and pharmaceutical compositions containing same |
| 01/26/2011 | EP2277570A2 Medical devices containing rapamycin analogs |
| 01/26/2011 | EP2277569A2 Medical devices containing rapamycin analogs |
| 01/26/2011 | EP2277568A2 Medical devices containing rapamycin analogs |
| 01/26/2011 | EP2277567A1 Medical devices containing rapamycin analogs |
| 01/26/2011 | EP2277566A2 Medical devices containing rapamycin analogs |
| 01/26/2011 | EP2277565A2 Medical devices containing rapamycin analogs |
| 01/26/2011 | EP2277552A1 Mnk kinase proteins and diabetes |
| 01/26/2011 | EP2277531A1 Treatment of cns damage |
| 01/26/2011 | EP2277529A1 Therapeutical application of SCF |
| 01/26/2011 | EP2277526A1 Pharmaceutical composition with tetrahydroisohumulone |
| 01/26/2011 | EP2277520A2 A pharmaceutical composition for angiotensin ii-mediated diseases |
| 01/26/2011 | EP2277519A2 Use of Angiotensin II type 1 receptor antagonists for the prevention of stroke, diabetes and/or congestive heart failure |
| 01/26/2011 | EP2276769A1 New peptidomimetic compounds |
| 01/26/2011 | EP2276761A1 Carboxamide compounds for the treatment of metabolic disorders |
| 01/26/2011 | EP2276742A1 Ivabradine hydrobromide |
| 01/26/2011 | EP2276738A1 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 01/26/2011 | EP2276737A1 4- [3- (aryloxy) benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors |
| 01/26/2011 | EP2276736A1 4- [3- (aryloxy) benzyliden]-3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 01/26/2011 | EP2276735A1 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors |
| 01/26/2011 | EP2276734A1 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors |
| 01/26/2011 | EP2276541A1 Maintenance of platelet inhibition during antiplatelet therapy |
| 01/26/2011 | EP2276504A1 Vascular aging inhibitor and anti-aging formulation |
| 01/26/2011 | EP2276480A2 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
| 01/26/2011 | EP2125804B1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
| 01/26/2011 | EP2086556B1 Mixed cell populations for tissue repair and separation technique for cell processing |
| 01/26/2011 | EP2086537B1 Imidazo[2,1-b]thiazoles and their use as pharmaceuticals |
| 01/26/2011 | EP2049515B1 Triazolyl pyridyl benzenesulfonamides as ccr2 or ccr9 modulators for the treatment of atherosclerosis |
| 01/26/2011 | EP2049514B1 Nitrate esters of piperidines |
| 01/26/2011 | EP1849795B1 1-substituted-7-( -d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 01/26/2011 | EP1615612B1 Pro-urokinase mutant for lysis of occlusive blood clots while sparing wound sealing clots in the treatment of stroke |
| 01/26/2011 | EP1446382B1 Anthranilic acid amides and their use as vegf receptor tyrosine kinase inhibitors |
| 01/26/2011 | CN1918128B Fused ring 4-oxopyrimidine derivative |
| 01/26/2011 | CN1796388B Sesamin/episesamin compositions |
| 01/26/2011 | CN101960307A High-molecular-weight adiponectin measurement method |
| 01/26/2011 | CN101959900A Glycosylated glycopeptide antibiotic derivative |
| 01/26/2011 | CN101959886A Imidazo[1,2-a]pyridine-2-carboxamide derivatives, preparation thereof and application thereof in therapeutics |
| 01/26/2011 | CN101959885A Derivatives of N-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 01/26/2011 | CN101959884A Derivatives of 6-heterocyclic-imidazo[l,2-alpha]pyrroine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 01/26/2011 | CN101959881A 5-O-substituted 3-N-phenyl-1,3,4-oxadiazolones for medical use |
| 01/26/2011 | CN101959866A Novel 1-benzyl-3-hydroxymethyilindazole derivatives and use thereof in the treatment of diseases based on the expression MCP-1 and CX3CR1 |
| 01/26/2011 | CN101959542A Drug delivery system |
| 01/26/2011 | CN101957346A Novel method for studying medicament metabolism by using model organism zebrafish |
| 01/26/2011 | CN101955974A Eukaryotic double-expression vector with human tissue factor pathway inhibiting factors and GFP (Green Fluorescent Protein) and construction method thereof |
| 01/26/2011 | CN101955512A Angiotensin I converting enzyme activity inhibiting oligopeptides as well as preparation method and application thereof |
| 01/26/2011 | CN101954082A Angiotensin-converting enzyme inhibitor-containing compound preparation for treating hypertension |
| 01/26/2011 | CN101954051A Traditional Chinese medicinal composite used for curing cerebral thrombosis |
| 01/26/2011 | CN101954029A Pills for loosening chest |
| 01/26/2011 | CN101954025A Traditional Chinese medicine for treating diabetic acro-necrosis |